Abstract: A razor assembled by folding includes a holding part that is held by a user, a head supporting part that is formed integrally with the holding part, and a razor head that is provided on the head supporting part. The entire of the holding part and the head supporting part is formed of paper. The entire of the razor head is formed of metal, and the razor head includes a blade body and a frame body housing the blade body.

Abstract: A link actuation apparatus that actuates a parallel link mechanism where a spherical drive mechanism is constructed includes a controller configured to calculate, based on spherical trigonometry, an attitude of a second link hub from angles ?A1 and ?A2 that represent the attitude of a first end link member with respect to a first link hub in two of at least three link mechanisms. The link actuation apparatus capable of performing forward transformation in real time is thus provided.

Abstract: A razor assembled by folding includes a holding part that is held by a user, a head supporting part that is formed integrally with the holding part, and a razor head that is provided on the head supporting part. The entire of the holding part and the head supporting part is formed of paper. The entire of the razor head is formed of metal, and the razor head includes a blade body and a frame body housing the blade body.

Abstract: A link actuation apparatus that actuates a parallel link mechanism where a spherical drive mechanism is constructed includes a controller configured to calculate, based on spherical trigonometry, an attitude of a second link hub from angles ?A1 and ?A2 that represent the attitude of a first end link member with respect to a first link hub in two of at least three link mechanisms. The link actuation apparatus capable of performing forward transformation in real time is thus provided.

Abstract: Realizing a constant-current control even in a stable state of a lamp without increasing a rated output of a power supply. In a stable state of the lamp in which a change value of a lamp voltage after a discharge lamp is turned on becomes less than a certain value, when the lamp voltage rises, a discharge lamp lighting control apparatus changes a current command value to perform a constant-current control. This change is a change from a first current command value at the time when the discharge lamp is turned on to a second current command value that is smaller than the former by a predetermined value. Using this second current command value, the constant-current control is performed. Even after that, the second current command value is changed to a smaller value every time the lamp voltage rises, and the constant-current control is performed using the second current command value.

Abstract: Realizing a constant-current control even in a stable state of a lamp without increasing a rated output of a power supply. In a stable state of the lamp in which a change value of a lamp voltage after a discharge lamp is turned on becomes less than a certain value, when the lamp voltage rises, a discharge lamp lighting control apparatus changes a current command value to perform a constant-current control. This change is a change from a first current command value at the time when the discharge lamp is turned on to a second current command value that is smaller than the former by a predetermined value. Using this second current command value, the constant-current control is performed. Even after that, the second current command value is changed to a smaller value every time the lamp voltage rises, and the constant-current control is performed using the second current command value.

Abstract: A composition for regenerative treatment of cartilage disease, which comprises a PDE4 inhibitor as an active ingredient, specifically a composition comprising a PDE4 inhibitor and a biocompatible and biodegradable polymer is provided, which composition, when formulated into a form suited to administer locally to affected cartilage region, such as microsphere preparation, can provide a pharmaceutical composition showing an excellent effect in regenerative treatment of cartilage.

Abstract: A composition for regenerative treatment of cartilage disease, which comprises a PDE4 inhibitor as an active ingredient, specifically a composition comprising a PDE4 inhibitor and a biocompatible and biodegradable polymer is provided, which composition, when formulated into a form suited to administer locally to affected cartilage region, such as microsphere preparation, can provide a pharmaceutical composition showing an excellent effect in regenerative treatment of cartilage.

Abstract: A composition for regenerative treatment of cartilage disease, which comprises a PDE4 inhibitor as an active ingredient, specifically a composition comprising a PDE4 inhibitor and a biocompatible and biodegradable polymer is provided, which composition, when formulated into a form suited to administer locally to affected cartilage region, such as microsphere preparation, can provide a pharmaceutical composition showing an excellent effect in regenerative treatment of cartilage.

Abstract: A composition for accelerating fracture healing, which has a PDE4 inhibitor as an active ingredient, specifically a composition having a PDE4 inhibitor and a biocompatible and biodegradable polymer is provided, which composition, when formulated into a form suitable for local administration such as a microsphere preparation, can provide a pharmaceutical composition showing an excellent effect in the early healing of bone fracture. The composition is useful in healing of refractory fracture of elderly people and diabetic or osteoporosis patients.

Abstract: A composition for accelerating fracture healing, which has a PDE4 inhibitor as an active ingredient, specifically a composition having a PDE4 inhibitor and a biocompatible and biodegradable polymer is provided, which composition, when formulated into a form suitable for local administration such as a microsphere preparation, can provide a pharmaceutical composition showing an excellent effect in the early healing of bone fracture. The composition is useful in healing of refractory fracture of elderly people and diabetic or osteoporosis patients.

Abstract: A composition for regenerative treatment of cartilage disease, which comprises a PDE4 inhibitor as an active ingredient, specifically a composition comprising a PDE4 inhibitor and a biocompatible and biodegradable polymer is provided, which composition, when formulated into a form suited to administer locally to affected cartilage region, such as microsphere preparation, can provide a pharmaceutical composition showing an excellent effect in regenerative treatment of cartilage.

Abstract: A composition for regenerative treatment of cartilage disease, which comprises a PDE4 inhibitor as an active ingredient, specifically a composition comprising a PDE4 inhibitor and a biocompatible and biodegradable polymer is provided, which composition, when formulated into a form suited to administer locally to affected cartilage region, such as microsphere preparation, can provide a pharmaceutical composition showing an excellent effect in regenerative treatment of cartilage.

Abstract: A composition for accelerating fracture healing, which comprises a PDE4 inhibitor as an active ingredient, specifically a composition comprising a PDE4 inhibitor and a biocompatible and biodegradable polymer is provided, which composition, when formulated into a form suitable for local administration such as microsphere preparation, can provide a pharmaceutical composition showing an excellent effect in the early healing of bone fracture. The said composition is useful in the healing of refractory fracture of elderly people and diabetic or osteoporosis patients.

Abstract: A coating method of a plastic parts comprises coating a primer paint on a work made of a black color family plastic, coating a color base paint containing a color pigment on a primer coating film formed by coating the primer paint, coating a base paint containing a effect pigment on a color base coating film formed by coating the color base paint, and coating a clear paint on a base coating film formed by coating the base paint. In the coating method, the primer paint contains a color pigment having L* value of 80 or more in CIE colorimetric system L*a*b*.